SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-064882
Filing Date
2024-05-28
Accepted
2024-05-28 07:15:15
Documents
13
Period of Report
2024-05-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnlx-20240524.htm   iXBRL 8-K 47002
2 EX-99.1 rnlx-ex99_1.htm EX-99.1 21235
3 GRAPHIC img102423453_0.jpg GRAPHIC 17643
  Complete submission text file 0000950170-24-064882.txt   251840

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnlx-20240524.xsd EX-101.SCH 51220
17 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20240524_htm.xml XML 5900
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 24986262
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)